One-Year Follow-Up of Cystic Fibrosis Patients Who Cannot Reach the Modulator Therapies Although Having Indications: What are Their Losses?

dc.contributor.authorUytun, S
dc.contributor.authorPolat, SE
dc.contributor.authorTabakçi, SÖ
dc.contributor.authorCinel, G
dc.contributor.authorEmiralioglu, N
dc.contributor.authorYalçin, E
dc.contributor.authorKiper, N
dc.contributor.authorSen,
dc.contributor.authorAltintas, DU
dc.contributor.authorÇokugras, H
dc.contributor.authorKilinç, AA
dc.contributor.authorYazan, H
dc.contributor.authorÇollak, A
dc.contributor.authorUzuner, S
dc.contributor.authorÜnal, G
dc.contributor.authorYilmaz, A
dc.contributor.authorÇelik, S
dc.contributor.authorDamadoglu, E
dc.contributor.authorIrmak, I
dc.contributor.authorDemir, E
dc.contributor.authorÖztürk, G
dc.contributor.authorBasaran, E
dc.contributor.authorBingöl, A
dc.contributor.authorSapan, N
dc.contributor.authorAslan, AT
dc.contributor.authorAsfuroglu, P
dc.contributor.authorHarmanci, K
dc.contributor.authorKöse, M
dc.contributor.authorHangül, M
dc.contributor.authorÖzdemir, A
dc.contributor.authorÖzcan, G
dc.contributor.authorGayretli, ZG
dc.contributor.authorKeskin, Ö
dc.contributor.authorYüksel, H
dc.contributor.authorÖzdogan, S
dc.contributor.authorTopal, E
dc.contributor.authorÇaltepe, G
dc.contributor.authorCan, D
dc.contributor.authorEkren, PK
dc.contributor.authorKiliç, M
dc.contributor.authorSüleyman, A
dc.contributor.authorEyüboglu, TS
dc.contributor.authorPekcan, S
dc.contributor.authorÇobanoglu, N
dc.contributor.authorÇakir, E
dc.contributor.authorÖzçelik, U
dc.contributor.authorDogru, D
dc.date.accessioned2025-04-10T10:37:37Z
dc.date.available2025-04-10T10:37:37Z
dc.identifier.e-issn1399-3003
dc.identifier.issn0903-1936
dc.identifier.urihttp://hdl.handle.net/20.500.14701/43133
dc.language.isoEnglish
dc.titleOne-Year Follow-Up of Cystic Fibrosis Patients Who Cannot Reach the Modulator Therapies Although Having Indications: What are Their Losses?
dc.typeMeeting Abstract

Files